41
total announcements
544445.BO · 15 min delayed
Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2026.
Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd has informed the BSE about a change in its registered office address, effective from October 15, 2026.
Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd has informed the BSE that its Board of Directors has approved the shifting of the company's Registered Office within the local limits of the same city and under the jurisdiction of the same Registrar of Companies. The new address will be effective from 15th October 2026.
Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/10/2026 to consider and approve the shifting of the registered office address, acquisition of immovable property, and other incidental matters.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.
ASSTON PHARMACEUTICALS LIMITED
Asston Pharmaceuticals has informed BSE about the appointment of a new statutory auditor.